You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccine immunogenicity

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)

Not yet recruiting
  • Iron Deficiency Anemia
  • Iron-fortified cookies
  • +3 more
  • (no location specified)
Aug 30, 2023

Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))

Active, not recruiting
  • Newborn Vaccine Immunogenicity
  • Hepatitis B vaccine (HBV)
  • Bacillus Calmette-Guérin (BCG)
  • Fajara, Gambia
  • +1 more
Jan 12, 2023

COVID-19, SARS-CoV-2 Infection Trial in United States (AZD9838, Licensed mRNA vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • AZD9838
  • Licensed mRNA vaccine
  • Long Beach, California
  • +4 more
Nov 24, 2023

Healthy Volunteers Trial in Changsha (Enterovirus Type 71 Vcacine)

Completed
  • Healthy Volunteers
  • Enterovirus Type 71 Vcacine
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 20, 2023

COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)

Recruiting
  • COVID-19
  • +3 more
  • Omicron-containing COVID-19 vaccine
  • influenza vaccine
  • Seoul, Guro-gu, Korea, Republic of
  • +1 more
Oct 17, 2023

Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single

Not yet recruiting
  • Safety of a Single Dose of COMVIGEN Vaccine
  • +5 more
  • Comvigen (Bivalent, ChulaCov19 BNA159.2)
  • BIVALENT Pfizer/BNT vaccine
  • Bangkok, Thailand
  • +1 more
Jun 29, 2023

Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)

Recruiting
  • Tetanus
  • Investigational tetanus vaccine, adsorbed
  • Control tetanus vaccine, adsorbed
  • Shangqiu, Henan, China
    Liangyuan District Center for Disease Control and Prevention
Sep 15, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10

Recruiting
  • SARS-CoV-2 Infection
  • Placebo
  • +4 more
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Nov 7, 2023

Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)

Not yet recruiting
  • Influenza
  • TetraFluvac TF vaccine
  • Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
May 30, 2023

Polio Trial (polio vaccines: nOPV2, bOPV, IPV)

Not yet recruiting
  • Polio
  • polio vaccines: nOPV2, bOPV, IPV
  • (no location specified)
Nov 2, 2023

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide

Recruiting
  • Pneumococcal Disease
  • 23-valent pneumococcal polysaccharide vaccine
  • control pneumococcal polysaccharide vaccine
  • Chengdu, Sichuan, China
    Sichuan Center For Disease Control and Prevention
Sep 19, 2023

Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)

Completed
  • Vaccine-Preventable Diseases
  • Hepatitis B
  • CVI-HBV-002
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA University Bundang Medical Center
Nov 19, 2023

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19 mRNA Vaccine (ZSVG-02-O)
  • COVID-19 Vaccine (Vero Cell) ,Inactivated
  • Dengfeng, Henan, China
  • +1 more
Nov 6, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)

Not yet recruiting
  • Vaccination; Infection
  • Vaccine Adverse Reaction
  • Recombinant zoster vaccination
  • (no location specified)
Jun 9, 2023

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023

COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

Recruiting
  • COVID-19
  • SARS-CoV-2 DNA Vaccine (ICCOV)
  • Wong Chuk Hang, Hong Kong
    Gleneagles Hospital Hong Kong
Jun 16, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • LYB001
  • CoronaVac
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)

Recruiting
  • Zoster
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023